Position in GILD
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$267,335
+$2,532 QoQ
Shares Held
2,116
+11.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#1,739
of 2,266 holders
Holding Since
Sep 2020
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Derivatives in GILD
reported options exposure · as of Sep 30, 2020CallValue
$7,000
CallShares
5,000
PutValue
$1,000
PutShares
5,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Tempus Wealth Planning, LLC holds $12,281,697 across 10 Drug Manufacturers - General names. GILD ranks #9 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,351 | $2,819,860 | |
| 2 | AMGN |
Amgen Inc
|
6,252 | $2,263,974 | |
| 3 | JNJ |
Johnson & Johnson
|
8,489 | $2,155,951 | |
| 4 | PFE |
Pfizer Inc
|
48,325 | $1,163,666 | |
| 5 | ABBV |
AbbVie Inc.
|
4,457 | $1,121,559 | |
| 6 | MRK |
Merck & Co., Inc.
|
7,491 | $962,593 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
15,761 | $908,148 | |
| 8 | NVO |
Novo Nordisk A S
|
7,909 | $379,157 |
All Filings in GILD
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $267,335 | 2,116 | Shares | Sole | 2026-07-22 | |
| 2026-03-31 | $264,803 | 1,900 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $225,105 | 1,834 | Shares | Sole | 2026-01-16 | |
| 2020-09-30 | $78,292 | 1,239 | Shares | Sole | 2020-11-12 | |
| 2020-09-30 | $7,000 | 5,000 | Call | Sole | 2020-11-12 | |
| 2020-09-30 | $1,000 | 5,000 | Put | Sole | 2020-11-12 | |
| No filing history on record for this holder in this stock. | ||||||